The Cancer Control and Supportive Care (CCSC) Research Program within University of Rochester Wilmot Cancer Institute (WCI) invites candidates to apply for full-time tenure-track faculty positions. Leadership opportunities within WCI and the University of Rochester Cancer Center (URCC) NCI Community Oncology Research Program (NCORP) Research Base with the potential for an Endowed Chair exist for appropriately qualified and experienced candidates. Wilmot is located in Rochester, NY, which is in the heart of Western New York on the border of Canada. Rochester is nestled between the southern shore of Lake Ontario, the Finger Lakes and the foothills of the Adirondack Mountains. Some of Rochester’s notable attractions include: the Erie Canal, the Genesee River, the National Museum of Play, the George Eastman Museum, the Rochester Philharmonic Orchestra, and the homes of Susan B. Anthony and Fredrick Douglas.
WCI is comprised of the James P. Wilmot Cancer Center—our flagship 86-bed, inpatient and outpatient facility located on the University of Rochester Academic Medical Center campus contiguous with Strong Memorial Hospital—and 11 additional outpatient locations covering a 16-county region surrounding Rochester. WCI offers patients as well as their family members and caregivers comprehensive services including: 1) one of upstate New York’s largest blood and bone marrow transplant programs, 2) the only ACOS-accredited Breast Cancer Center in our region, and 3) the first Geriatric, Survivorship and Integrative Oncology Clinical Programs in our region.
WCI’s CCSC Research Program has been conducting cancer control and cancer care delivery research with continuous funding from the National Cancer Institute (NCI) for more than 40 years. Under the direction of Drs. Mustian, Mohile and Morrow the investigators in this Program work towards a common vision to “help good people through lousy times when they experience cancer.” The CCSC Program is comprised of 40 highly-collaborative faculty members conducting cancer prevention, cancer control and cancer care delivery research across 4 schools and 15 departments. Members of the CCSC program include more than 10 faculty members who are internationally renowned for their landmark contributions to the field of oncology in specialty areas including: primary prevention, cancer control, supportive care, behavioral oncology, exercise oncology, geriatric oncology, survivorship, and training. CCSC investigators also have access to all WCI shared resources including: 1) the biostatistics and bioinformatics core, 2) the clinical trials office and infrastructure, 3) the genomics research center, 4) a tissue bio-specimen repository, 4) the cancer center psychoneuroimmunology laboratory, and 5) the PEAK Human Performance Clinical Research Laboratory. The CCSC Research Program is supported by a total of over $34 million in current extramural NCI funding and additional funding from the WCI.
In addition to connection in a highly collaborative community of investigators, members of the CCSC and WCI have access to four extremely valuable resources:
- The University of Rochester Cancer Center NCI Community Oncology Research Program (URCC NCORP) Research Base (MPIs Mustian and Morrow): WCI is home to one of only two NCI-funded NCORP Research Bases in the United States in an Academic Medical Center. The URCC NCORP Research Base is a legacy Research base with a long and sustained track record of funding, success and growth. URCC is one of the original Research Bases that were funded within the NCI Community Clinical Oncology Program (CCOP) in 1983—the predecessor to today’s NCORP. The URCC NCORP Research Base is a research hub for investigators where they can utilize a network of 20 NCI-funded community-based NCORP affiliates across the United States, which includes more than 600 geographically different community-based oncology practices and a highly-efficient infrastructure for clinical trial recruitment. This resource provides unique sources of collegial support, scientific expertise, and infrastructure to aid with development of scientific ideas and grants, as well as, the conduct of studies within the regional WCI catchment area and the national NCORP catchment area.
- The Center for Research on Flavored Tobacco Products (CRoFT; WCI MPIs Rahmen, Ossip and McIntosh): WCI is one of a select few cancer centers in the U.S. with a Tobacco Center for Regulatory Research. Our recently funded center, is a collaborative center with Roswell Park Cancer Institute. CRoFT foci include four main areas: 1) Assessing Flavorant Toxicity, 2) Characterizing Flavors and Their Impact on Behavior, 3) Determining Respiratory Health Effects of Flavors, and 4) Evaluating the Effects of Product Marketing. This center also provides CCSC investigators with access to unique cores and pilot funding.
- The Clinical and Translational Science Institute: The University of Rochester Medical Center was one of the first 12 academic medical centers in the country to receive a Clinical and Translational Science Award (CTSA) 2006 and has been continuously funded since that time. The initial $40 million grant allowed URMC to leverage additional funding and build the $60 million Saunders Research Building, which brings clinical and translational scientists, as well as, resources (e.g., URCC NCORP, CCSC, others) together under one roof. CCSC investigators have access to all of the CTSI infrastructure, services, spaces and pilot funding provided by the CTSI.
Successful candidates will join the CCSC Research Program and receive faculty appointments in departments commensurate with their expertise. Requirements include a doctoral level degree (e.g., PHD, MD) with a track record of independent funding at the R01 equivalent level. Investigators with research foci in cancer prevention and control or cancer care delivery specializing in symptom management (e.g., fatigue, cognition, insomnia, neuropathy, etc.), exercise oncology, health disparities (esp. among rural populations), geriatric oncology, integrative oncology, behavioral oncology, and nutrition and cancer are strongly encouraged to apply. Candidates with research expertise in other areas are also strongly encouraged to apply. Candidates should be recognized as national and international leaders in their fields, have a successful track record of scholarly production with recognizable and significant impact, and have an established extramurally-funded research program including National Institutes of Health and, ideally, National Cancer Institute support.
The candidate will interact with basic, translational, and clinical scientists across all research programs within the WCI. The successful applicant will be expected to maintain an innovative, independent, collaborative and extramurally-funded research program. This is a continuing full time position at the tenure-eligible or tenured level with a middle to senior faculty rank. Recruitment packages will include a competitive negotiable salary, excellent benefits and additional negotiable resources commensurate with rank, funding and experience. An appointment in the academic department/school will be supported and will be determined based on the optimal fit with the candidate’s clinical research and disciplinary orientation. Academic rank will be commensurate with qualifications and experience. Applications will be accepted until the position is filled. Proposed start dates are open. The position(s) will be filled as soon as suitable candidates are identified.
The University of Rochester Medical Center is an Equal Opportunity, Affirmative Action Employer of all protected classes, including veterans and individuals with disabilities. Women, racial and ethnic minorities, individuals with disabilities, and veterans are strongly encouraged to apply. Hiring is contingent upon eligibility to work in the U.S.